Annual ROE
-47.07%
-15.70%-50.05%
31 December 2023
Summary:
Cardiff Oncology annual return on equity is currently -47.07%, with the most recent change of -15.70% (-50.05%) on 31 December 2023. During the last 3 years, it has fallen by -18.57% (-65.16%). CRDF annual ROE is now -143.15% below its all-time high of 109.08%, reached on 31 December 2010.CRDF ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-69.27%
-10.47%-17.81%
30 September 2024
Summary:
Cardiff Oncology quarterly return on equity is currently -69.27%, with the most recent change of -10.47% (-17.81%) on 30 September 2024. Over the past year, it has dropped by -26.81% (-63.14%). CRDF quarterly ROE is now -112.19% below its all-time high of 568.30%, reached on 30 June 2012.CRDF Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDF ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -50.0% | -63.1% |
| 3 y3 years | -65.2% | -204.3% |
| 5 y5 years | +76.3% | +58.2% |
CRDF ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -123.4% | at low | -226.1% | at low |
| 5 y | 5 years | -123.4% | +76.3% | -226.1% | +67.7% |
| alltime | all time | -143.2% | +91.2% | -112.2% | +95.1% |
Cardiff Oncology ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -69.27%(+17.8%) |
| June 2024 | - | -58.80%(+14.5%) |
| Mar 2024 | - | -51.37%(+8.3%) |
| Dec 2023 | -47.07%(+50.0%) | -47.42%(+11.7%) |
| Sept 2023 | - | -42.46%(+12.1%) |
| June 2023 | - | -37.89%(+10.3%) |
| Mar 2023 | - | -34.36%(+8.4%) |
| Dec 2022 | -31.37%(+48.9%) | -31.70%(+2.5%) |
| Sept 2022 | - | -30.93%(+8.6%) |
| June 2022 | - | -28.48%(+11.5%) |
| Mar 2022 | - | -25.54%(+20.2%) |
| Dec 2021 | -21.07%(-26.1%) | -21.24%(-6.7%) |
| Sept 2021 | - | -22.76%(-11.1%) |
| June 2021 | - | -25.60%(-20.4%) |
| Mar 2021 | - | -32.17%(-33.5%) |
| Dec 2020 | -28.50%(-84.9%) | -48.38%(-55.5%) |
| Sept 2020 | - | -108.65%(-30.2%) |
| June 2020 | - | -155.57%(-27.6%) |
| Mar 2020 | - | -214.75%(+11.4%) |
| Dec 2019 | -188.72%(-4.9%) | -192.72%(+16.3%) |
| Sept 2019 | - | -165.77%(+24.8%) |
| June 2019 | - | -132.82%(-4.7%) |
| Mar 2019 | - | -139.34%(-10.7%) |
| Dec 2018 | -198.44% | -156.10%(-2.2%) |
| Sept 2018 | - | -159.62%(-25.1%) |
| June 2018 | - | -213.11%(-36.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | -335.82%(+19.8%) |
| Dec 2017 | -189.59%(+65.6%) | -280.42%(+17.4%) |
| Sept 2017 | - | -238.76%(+21.1%) |
| June 2017 | - | -197.11%(+32.6%) |
| Mar 2017 | - | -148.68%(+28.2%) |
| Dec 2016 | -114.51%(+18.9%) | -116.00%(+24.5%) |
| Sept 2016 | - | -93.20%(+19.1%) |
| June 2016 | - | -78.25%(-4.5%) |
| Mar 2016 | - | -81.97%(-8.3%) |
| Dec 2015 | -96.30%(-3.4%) | -89.43%(-15.4%) |
| Sept 2015 | - | -105.65%(-38.6%) |
| June 2015 | - | -171.95%(+49.0%) |
| Mar 2015 | - | -115.38%(+22.7%) |
| Dec 2014 | -99.68%(-4.8%) | -94.03%(+56.8%) |
| Sept 2014 | - | -59.97%(-8.3%) |
| June 2014 | - | -65.40%(-45.1%) |
| Mar 2014 | - | -119.03%(-13.8%) |
| Dec 2013 | -104.70%(-80.4%) | -138.10%(-55.9%) |
| Sept 2013 | - | -312.81%(-45.2%) |
| June 2013 | - | -570.93%(-2.5%) |
| Mar 2013 | - | -585.34%(-58.8%) |
| Dec 2012 | -533.24%(-1107.6%) | -1421.42%(+4.1%) |
| Sept 2012 | - | -1366.02%(-340.4%) |
| June 2012 | - | 568.30%(+754.1%) |
| Mar 2012 | - | 66.54%(+25.7%) |
| Dec 2011 | 52.92%(-51.5%) | 52.92% |
| Dec 2010 | 109.08% | - |
FAQ
- What is Cardiff Oncology annual return on equity?
- What is the all time high annual ROE for Cardiff Oncology?
- What is Cardiff Oncology annual ROE year-on-year change?
- What is Cardiff Oncology quarterly return on equity?
- What is the all time high quarterly ROE for Cardiff Oncology?
- What is Cardiff Oncology quarterly ROE year-on-year change?
What is Cardiff Oncology annual return on equity?
The current annual ROE of CRDF is -47.07%
What is the all time high annual ROE for Cardiff Oncology?
Cardiff Oncology all-time high annual return on equity is 109.08%
What is Cardiff Oncology annual ROE year-on-year change?
Over the past year, CRDF annual return on equity has changed by -15.70% (-50.05%)
What is Cardiff Oncology quarterly return on equity?
The current quarterly ROE of CRDF is -69.27%
What is the all time high quarterly ROE for Cardiff Oncology?
Cardiff Oncology all-time high quarterly return on equity is 568.30%
What is Cardiff Oncology quarterly ROE year-on-year change?
Over the past year, CRDF quarterly return on equity has changed by -26.81% (-63.14%)